English
This article is from Journal of Pharmacology & Pharmacotherapeutics , volume 5 . Abstract Off-label prescribing of medicines is prevalent worldwide because it gives freedom to physicians to apply new therapeutic options based on the latest evidence. Although physicians may lawfully prescribe approved drugs for any use consistent with available scientific data and proper medical practice, but unfortunately, usually this is done without adequate scientific data. Often, when the best available therapeutic option fails, patients demand new approach or new treatment which ultimately leads to off-label uses. Major concerns about efficacy and safety have been raised by inappropriate use of off-label drugs because it leads to drug being used without risk-benefit analysis by the regulatory agency. Although the regulatory approval process requires ample proof of efficacy and safety for granting approval for specific indications of prescription drugs but unfortunately, more clarity is required about regulations governing off-label use of medicine. Above all because of the financial aspects involved it is highly impractical to expect that pharmaceutical companies will restrict or stop off-labe
Sign in with your free account to read, download EPUBs or listen.
Ebook · Off-label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities. · Gupta, Sandeep Kumar, Nayak, Roopa Prasad · Internet Archive